Last 48 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 17.27 | — | 31.89 | 15.71 | 15.11 | 16.73 | 15.25 | 14.38 | 19.90 | 24.35 | 19.42 | 14.10 | 12.09 |
| — | — | +109.2% | +9.3% | -24.1% | -31.3% | -21.5% | +1.9% | +64.6% | -71.7% | -6.0% | -14.3% | -36.2% | |
| P/S Ratio | 0.17 | 0.19 | 0.22 | 0.35 | 0.40 | 0.40 | 0.48 | 0.44 | 0.60 | 0.58 | 0.56 | 0.52 | 0.48 |
| — | -51.5% | -53.5% | -19.2% | -32.9% | -31.2% | -13.7% | -16.4% | +26.7% | -0.9% | -7.0% | +3.3% | -24.5% | |
| P/B Ratio | 2.00 | 2.17 | 2.45 | 3.51 | 4.19 | 3.74 | 4.17 | 3.57 | 5.33 | 4.99 | 4.91 | 4.82 | 4.72 |
| — | -42.0% | -41.3% | -1.6% | -21.4% | -25.1% | -15.1% | -25.8% | +13.0% | -23.3% | -21.4% | -16.5% | -32.7% | |
| P/FCF | — | — | — | — | 26.86 | — | 5.93 | — | 32.02 | — | 5.16 | 9.56 | 4.39 |
| — | — | — | — | -16.1% | — | +14.9% | — | +629.8% | — | -75.8% | -20.1% | -69.5% | |
| EV / EBITDA | 7.82 | — | 13.58 | 8.84 | 8.82 | 8.91 | 8.60 | 7.99 | 11.58 | 12.93 | 9.89 | 7.69 | 6.68 |
| — | — | +58.0% | +10.7% | -23.9% | -31.1% | -13.1% | +3.9% | +73.3% | -55.5% | -12.3% | -13.6% | -35.8% | |
| EV / EBIT | 9.78 | — | 18.04 | 10.21 | 9.79 | 10.03 | 9.46 | 8.83 | 12.81 | 14.69 | 11.05 | 8.42 | 7.33 |
| — | — | +90.7% | +15.6% | -23.5% | -31.7% | -14.3% | +4.9% | +74.7% | -65.1% | -13.7% | -15.7% | -36.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Molina Healthcare, Inc.'s operating margin was -1.4% in Q4 2025, down 2.6 pp QoQ and down 5.0 pp YoY. This marks the 4th consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 1.7% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 8.1% | 10.2% | 11.5% | 10.6% | 11.5% | 12.3% | 12.3% | 11.5% | 12.5% | 13.5% | 13.6% |
| — | — | -29.8% | -16.9% | -6.5% | -7.9% | -7.8% | -8.6% | -9.5% | -5.7% | +3.4% | +12.0% | +5.6% | |
| Operating Margin | 1.7% | -1.4% | 1.2% | 3.3% | 3.9% | 3.6% | 4.5% | 4.4% | 4.3% | 3.5% | 4.2% | 5.3% | 5.6% |
| — | -139.3% | -73.6% | -25.7% | -9.4% | +3.6% | +7.5% | -17.4% | -23.2% | +173.5% | -0.6% | +18.7% | +16.6% | |
| Net Margin | 1.0% | -1.4% | 0.7% | 2.2% | 2.7% | 2.4% | 3.2% | 3.0% | 3.0% | 2.4% | 2.9% | 3.7% | 3.9% |
| — | -158.8% | -78.2% | -26.8% | -11.8% | +0.1% | +10.0% | -17.9% | -23.1% | +250.6% | -1.2% | +20.5% | +18.6% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.0% | -3.9% | 1.8% | 5.7% | 6.8% | 5.4% | 6.8% | 6.4% | 6.9% | 5.3% | 6.5% | 8.9% | 10.3% |
| — | -171.5% | -73.5% | -11.3% | -2.1% | +1.5% | +3.8% | -27.9% | -32.7% | +186.2% | -16.6% | +1.4% | +7.9% | |
| ROA | 3.0% | -1.0% | 0.5% | 1.6% | 1.9% | 1.6% | 2.1% | 2.0% | 2.0% | 1.5% | 1.7% | 2.3% | 2.5% |
| — | -164.0% | -76.5% | -20.2% | -6.0% | +10.2% | +22.7% | -14.2% | -20.8% | +225.4% | -5.3% | +14.9% | +19.0% | |
| ROIC | 17.4% | -3.2% | 2.7% | 8.1% | 10.5% | 10.3% | 12.9% | 12.4% | 15.5% | 19.4% | 30.2% | 30.1% | 27.7% |
| — | -131.0% | -78.7% | -34.7% | -32.2% | -46.7% | -57.3% | -58.7% | -43.9% | +212.8% | +26.1% | -28.3% | -52.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.97 | 0.97 | 0.92 | 0.77 | 0.87 | 0.69 | 0.53 | 0.49 | 0.53 | 0.57 | 0.61 | 0.66 | 0.72 |
| — | +40.0% | +73.4% | +57.2% | +64.8% | +22.6% | -13.5% | -25.1% | -26.8% | -29.9% | -22.1% | -22.2% | -15.4% | |
| Debt / EBITDA | 4.05 | — | 21.16 | 8.27 | 7.83 | 7.29 | 4.92 | 4.97 | 5.06 | 6.64 | 5.93 | 4.91 | 4.77 |
| — | — | +330.2% | +66.4% | +54.8% | +9.7% | -17.0% | +1.2% | +6.0% | -57.8% | -5.8% | -16.8% | -17.8% | |
| Current Ratio | 1.69 | 1.69 | 1.68 | 1.66 | 1.63 | 1.62 | 1.55 | 1.57 | 1.49 | 1.54 | 1.47 | 1.52 | 1.47 |
| — | +4.3% | +8.6% | +5.8% | +9.3% | +5.4% | +5.2% | +3.7% | +1.5% | +4.4% | +1.3% | +6.1% | +1.7% | |
| Quick Ratio | 1.69 | 1.69 | 1.68 | 1.66 | 1.63 | 1.62 | 1.55 | 1.57 | 1.49 | 1.54 | 1.47 | 1.52 | 1.47 |
| — | +4.3% | +8.6% | +5.8% | +9.3% | +5.4% | +5.2% | +3.7% | +1.5% | +4.4% | +1.3% | +6.1% | +1.7% | |
| Interest Coverage | 4.07 | -3.12 | 2.80 | 7.77 | 10.07 | 11.18 | 16.10 | 15.50 | 15.78 | 11.70 | 13.30 | 16.41 | 16.25 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonMolina Healthcare, Inc.'s current P/E is 17.3x. The average P/E over the last 3 quarters is 20.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Molina Healthcare, Inc.'s current operating margin is 1.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Molina Healthcare, Inc.'s business trajectory between earnings reports.